{"id":386318,"date":"2020-09-25T00:00:00","date_gmt":"2020-09-25T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360vd0002-medtech-deep-venous-disease-treatment-devices-market-insights-global-2021\/"},"modified":"2026-04-17T23:08:01","modified_gmt":"2026-04-17T23:08:01","slug":"m360vd0002-medtech-deep-venous-disease-treatment-devices-market-insights-global-2021","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360vd0002-medtech-deep-venous-disease-treatment-devices-market-insights-global-2021\/","title":{"rendered":"Deep Venous Disease Treatment Devices | Market Insights | Global | 2021"},"content":{"rendered":"<p>The global market for deep venous disease treatment devices consists of a combination of the mature deep venous disease treatment thrombectomy and thrombolysis and\u00a0PTA balloon catheter segments, along with the evolving PV stent market. This market will\u00a0grow moderately across all geographies covered through 2029, driven by increasing adoption of endovascular treatment modalities in the treatment of deep venous disease and introduction of new and innovative technologies. However, the market will be impacted in the short term by the COVID-19 pandemic.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the current state of the global market for deep venous disease treatment devices\u00a0across a 10-year period.<\/p>\n","protected":false},"template":"","class_list":["post-386318","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-date-945"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386318","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386318\/revisions"}],"predecessor-version":[{"id":387827,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386318\/revisions\/387827"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=386318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}